XTL Biopharmaceuticals Lt... (XTLB)

AI Score

Unlock

1.13

-0.03 (-2.59%)

At close: Apr 17, 2025, 2:23 PM

1.16

2.85%

After-hours: Apr 17, 2025, 02:23 PM EDT

XTL Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	820K	594K	1.07M	1.4M	1.46M	1.59M	1.9M	2.09M	2.23M	2.35M	2.79M	2.97M	3.01M	2.92M	3.39M	3.63M	3.75M	4.03M	4.26M	4.46M	4.64M	4.76M	5.06M	3.25M	1.08M	1.14M	1.02M	3.29M	6.08M	6.33M	6.75M	2.02M	2.32M	2.6M	3.11M
Short-Term Investments	900K	992K	1.27M	605K	749K	794K	972K	1.63M	2.16M	2.81M	n/a	3.16M	n/a	3.38M	n/a	2.41M	n/a	n/a	n/a	2.27M	n/a	n/a	n/a	4.87M	4.33M	4.32M	4.52M	2.81M	317.00	n/a	n/a	414K	n/a	362K	n/a
Long-Term Investments	n/a	n/a	n/a	-604.39K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	604.39K	n/a	n/a	n/a	n/a	n/a	n/a	381K	n/a	382K	n/a	382K	n/a	382K	381K	382K	n/a	381.62K	381.62K	381.62K	n/a	n/a	379.62K	379.62K	n/a	380.62K	380K	390K	n/a	1.12M	10K	1.12M
Receivables	140K	304K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	85K	n/a	n/a	n/a	130K	n/a	-250	n/a
Other Current Assets	127K	128K	150K	11K	n/a	n/a	n/a	14K	n/a	n/a	3.45M	16K	3.46M	n/a	3.54M	13K	2.08M	2.38M	2.63M	20K	3.27M	4.41M	6.99M	n/a	1.68M	598K	508K	n/a	42K	467K	651K	191K	612K	n/a	527K
Total Current Assets	1.99M	2.02M	2.55M	2.05M	2.28M	2.5M	2.94M	3.81M	4.52M	5.38M	6.24M	6.24M	6.47M	6.57M	6.93M	6.12M	5.83M	6.41M	6.89M	6.83M	7.91M	9.17M	12.05M	8.2M	7.09M	6.06M	6.05M	6.21M	6.44M	6.79M	7.41M	2.75M	2.93M	3.22M	3.64M
Property-Plant & Equipment	217K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	n/a	1K	n/a	2K	n/a	2K	n/a	n/a	n/a	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	n/a	9K	n/a
Goodwill & Intangibles	7.08M	380K	380K	380K	380K	380K	380K	380K	380K	380K	n/a	380K	n/a	380K	n/a	380K	n/a	n/a	n/a	380K	382.00	382.00	382.00	380K	380K	380.00	380.00	380K	381.00	n/a	n/a	253K	n/a	1.1M	n/a
Total Long-Term Assets	7.29M	380K	380K	380K	380K	380K	380K	380K	380K	381K	381K	381K	382K	382K	382K	382K	382K	381K	382K	382K	382K	382K	382K	380K	380K	380K	380K	380K	381K	380K	390K	263K	1.12M	1.12M	1.12M
Total Assets	9.28M	2.4M	2.93M	2.43M	2.66M	2.88M	3.32M	4.19M	4.9M	5.76M	6.62M	6.62M	6.86M	6.95M	7.31M	6.5M	6.21M	6.79M	7.27M	7.21M	8.29M	9.55M	12.43M	8.57M	7.47M	6.44M	6.43M	6.59M	6.83M	7.17M	7.8M	3.02M	4.06M	4.34M	4.76M
Account Payables	554K	165K	223K	1K	162K	163K	241K	2K	153K	172K	n/a	2K	185K	258K	n/a	2K	n/a	n/a	n/a	1K	n/a	n/a	n/a	8K	n/a	n/a	n/a	4K	7K	n/a	n/a	17K	n/a	68K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	168K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	279K	n/a	n/a	n/a	n/a	190K	n/a
Total Current Liabilities	2.47M	165K	223K	206K	162K	163K	241K	187K	153K	172K	260K	231K	185K	258K	251K	254K	182K	194K	244K	232K	200K	203K	236K	253K	197K	198K	232K	300K	286K	382K	544K	330K	231.00	258K	372.00
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	765K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22K	517K	1.05M	3.59M	3.41M	2.69M	2.64M	n/a	n/a	n/a	465K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.67M	2.92M	4.7M	3.75M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22K	517K	1.05M	3.59M	3.41M	2.69M	2.64M	n/a	n/a	n/a	465K	n/a	n/a	n/a	1.05M	n/a	n/a	n/a	2.67M	2.92M	4.7M	3.75M	n/a	n/a	n/a	n/a
Total Liabilities	3.56M	165K	223K	206K	162K	163K	241K	187K	153K	194K	777K	1.28M	3.78M	3.67M	2.94M	254K	182K	194K	244K	232K	200K	203K	236K	253K	197K	198K	232K	2.97M	3.21M	5.08M	4.29M	330K	231.00	258K	372.00
Total Debt	168K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	23.14M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	14.12M	5.84K	14.12M	3.08K	13.6M	4.37K	13.18M	6.03K	6.59K	7.03K	13.18M	8.09K	9.35K	12.2K	13.18M	7.27K	6.24K	6.2K	13.18M	13.18M	13.18M	3.5K	6.62M	3.83K	6.62M	4.39K
Retained Earnings	-158.77M	-158.23M	-157.76M	-158.25M	-157.97M	-157.75M	-157.38M	-156.47M	-155.72M	-154.9M	n/a	-155.13M	n/a	-156.45M	n/a	-154.66M	n/a	n/a	n/a	-153.93M	n/a	n/a	n/a	-152.59M	n/a	n/a	n/a	-155.65M	-155.65M	-157.24M	n/a	-154.9M	n/a	-153.46M	n/a
Comprehensive Income	20K	20K	20K	20K	20K	20K	20K	20K	20K	20K	n/a	20K	n/a	20K	n/a	20K	n/a	n/a	n/a	20K	n/a	n/a	n/a	20K	n/a	n/a	n/a	67K	86K	145K	n/a	183K	n/a	131K	n/a
Shareholders Equity	5.72M	2.23M	2.71M	2.22M	2.5M	2.72M	3.08M	4M	4.74M	5.56M	5.84M	5.33M	3.08M	3.28M	4.37M	6.25M	6.03M	6.59M	7.03M	6.98M	8.09M	9.35M	12.2M	8.32M	7.27M	6.24M	6.2M	3.62M	3.62M	2.09M	3.5M	2.69M	3.83M	4.08M	4.39M
Total Investments	900K	992K	1.27M	605.00	749K	794K	972K	1.63M	2.16M	2.81M	n/a	3.16M	n/a	3.38M	n/a	2.41M	n/a	n/a	n/a	2.27M	n/a	n/a	n/a	4.87M	4.33M	4.32M	4.52M	2.81M	317.00	n/a	n/a	414K	n/a	362K	n/a